Literature DB >> 17657467

Cholinergic status modulations in human volunteers under acute inflammation.

Keren Ofek1, Karen S Krabbe, Tama Evron, Meir Debecco, Anders R Nielsen, Helle Brunnsgaad, Raz Yirmiya, Hermona Soreq, Bente K Pedersen.   

Abstract

Cholinergic Status, the total soluble circulation capacity for acetylcholine hydrolysis, was tested for putative involvement in individual variabilities of the recruitment of immune cells in response to endotoxin challenge. Young (average age 26) and elderly (average age 70) volunteers injected with either Escherichia coli endotoxin or saline on two different occasions were first designated Enhancers and Suppressors if they showed increase or decrease, respectively, in plasma acetylcholinesterase (AChE) activity 1.5 h after endotoxin administration compared to saline. Enhancers showed significant co-increases in plasma butyrylcholinesterase (BChE) and paraoxonase (PON1) activities, accompanied by rapid recovery of lymphocyte counts. Young Enhancers alone showed pronounced post-exposure increases in the pro-inflammatory cytokine interleukin-6 (IL-6), and upregulation of the normally rare, stress-induced AChE-R variant, suggesting age-associated exhaustion of the cholinergic effects on recruiting innate immune reactions to endotoxin challenge. Importantly, IL-6 injected to young volunteers or administered in vitro to primary mononuclear blood cells caused upregulation of AChE, but not BChE or PON1, excluding it from being the sole cause for this extended response. Interestingly, Suppressors but not Enhancers showed improved post-exposure working memory performance, indicating that limited cholinergic reactions may be beneficial for cognition. Our findings establish Cholinergic Status modulations as early facilitators and predictors of individual variabilities in the peripheral response to infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657467     DOI: 10.1007/s00109-007-0226-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  48 in total

Review 1.  The stressed hippocampus, synaptic plasticity and lost memories.

Authors:  Jeansok J Kim; David M Diamond
Journal:  Nat Rev Neurosci       Date:  2002-06       Impact factor: 34.870

Review 2.  Genetics and pathophysiology of mental retardation.

Authors:  Jamel Chelly; Malik Khelfaoui; Fiona Francis; Beldjord Chérif; Thierry Bienvenu
Journal:  Eur J Hum Genet       Date:  2006-06       Impact factor: 4.246

3.  Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses.

Authors:  Dan Grisaru; Marjorie Pick; Chava Perry; Ella H Sklan; Ronit Almog; Ilan Goldberg; Elizabeth Naparstek; Joseph B Lessing; Hermona Soreq; Varda Deutsch
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

4.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases.

Authors:  M Shapira; I Tur-Kaspa; L Bosgraaf; N Livni; A D Grant; D Grisaru; M Korner; R P Ebstein; H Soreq
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.

Authors:  L Capuron; A Ravaud; R Dantzer
Journal:  Psychosom Med       Date:  2001 May-Jun       Impact factor: 4.312

7.  Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production.

Authors:  Yehuda Pollak; Adi Gilboa; Ofra Ben-Menachem; Tamir Ben-Hur; Hermona Soreq; Raz Yirmiya
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

8.  Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.

Authors:  K R Feingold; R A Memon; A H Moser; C Grunfeld
Journal:  Atherosclerosis       Date:  1998-08       Impact factor: 5.162

9.  Acute stress facilitates long-lasting changes in cholinergic gene expression.

Authors:  D Kaufer; A Friedman; S Seidman; H Soreq
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

10.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  33 in total

Review 1.  Cholinergic control of inflammation.

Authors:  M Rosas-Ballina; K J Tracey
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

2.  Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.

Authors:  Yaron Arbel; Shani Shenhar-Tsarfaty; Nir Waiskopf; Ariel Finkelstein; Amir Halkin; Miri Revivo; Shlomo Berliner; Itzhak Herz; Itzhak Shapira; Gad Keren; Hermona Soreq; Shmuel Banai
Journal:  Mol Med       Date:  2014-02-12       Impact factor: 6.354

3.  Diurnal Variation of the Peripheral Cholinergic Antiinflammatory Function in Mice.

Authors:  Bo-Shi Fan; En-Hui Zhang; Ming-He Cheng; Zhao-Tang Wu; Bing Han; Jian-Guang Yu
Journal:  CNS Neurosci Ther       Date:  2016-06-16       Impact factor: 5.243

Review 4.  Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease.

Authors:  Shani Shenhar-Tsarfaty; Shlomo Berliner; Natan M Bornstein; Hermona Soreq
Journal:  J Mol Neurosci       Date:  2013-11-20       Impact factor: 3.444

5.  Physiologic variability at the verge of systemic inflammation: multiscale entropy of heart rate variability is affected by very low doses of endotoxin.

Authors:  Georg N Herlitz; Renee L Arlow; Nora H Cheung; Susette M Coyle; Benjamin Griffel; Marie A Macor; Stephen F Lowry; Steve E Calvano; Stephen C Gale
Journal:  Shock       Date:  2015-02       Impact factor: 3.454

6.  Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.

Authors:  Einor Ben Assayag; Shani Shenhar-Tsarfaty; Keren Ofek; Lilach Soreq; Irena Bova; Ludmila Shopin; Ronan M G Berg; Shlomo Berliner; Itzhak Shapira; Natan M Bornstein; Hermona Soreq
Journal:  Mol Med       Date:  2010-04-14       Impact factor: 6.354

7.  Endotoxemia-induced inflammation and the effect on the human brain.

Authors:  Mark van den Boogaard; Bart P Ramakers; Nens van Alfen; Sieberen P van der Werf; Wilhelmina F Fick; Cornelia W Hoedemaekers; Marcel M Verbeek; Lisette Schoonhoven; Johannes G van der Hoeven; Peter Pickkers
Journal:  Crit Care       Date:  2010-05-05       Impact factor: 9.097

Review 8.  The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation.

Authors:  Stephen F Lowry
Journal:  Surg Clin North Am       Date:  2009-04       Impact factor: 2.741

9.  Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trial.

Authors:  Badar U Jan; Susette M Coyle; Leo O Oikawa; Shou-En Lu; Steve E Calvano; Paul M Lehrer; Stephen F Lowry
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

10.  The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.

Authors:  Erez Podoly; Deborah E Shalev; Shani Shenhar-Tsarfaty; Estelle R Bennett; Einor Ben Assayag; Harvey Wilgus; Oded Livnah; Hermona Soreq
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.